In liver cancer, overexpression of MEF2D is associated with tumor cell proliferation, invasion and metastasis, and immunosuppression (Ma et al., 2014; Yan et al., 2019; Xiang et al., 2020). The gene discussed is MEF2D; the disease is neoplasm.